Background: The baculovirus Autographa californica multiple nucleopolyhe-drovirus (AcMNPV) has been explored as a gene delivery vehicle for a variety of mammalian cell lines. However, the transient expression nature due to its incapability to replicate in mammalian cells and insufficient transduction efficiency limit its application. Methods: Recombinant baculovirus vectors containing genetic elements from Epstein-Barr virus (EBV), OriP and EBNA-1, which are essential for the episomal maintenance of the EBV genome in latently infected cells, were constructed and tested for their ability to sustain and express transgene (enhanced green fluorescence protein (egfp)) in mammalian cells. Results: The recombinant baculovirus containing OriP and EBNA-1 genes driven by the cytomegalovirus (CMV) promoter was capable of persisting in a significant proportion of infected mammalian cells, HEK293, Vero, Cos-7, and Hone-1, without any selective pressure. In HEK293, the expression of EGFP lasted for 60 days with markedly enhanced expression level. The persistence of baculovirus genome correlated with the expression of EBNA-1. Conclusions: The improved baculovirus vector could mediate prolonged and enhanced foreign gene expression in some mammalian cells. Furthermore, an adequate level of the EBNA-1 protein was essential for the maintenance of the OriP-containing baculovirus genome. The new vector has potential for use in gene therapy.

Original languageEnglish
Pages (from-to)1400-1406
Number of pages7
JournalJournal of Gene Medicine
Issue number12
StatePublished - Dec 2006


  • Baculovirus vector
  • Epstein-Barr virus
  • Gene therapy
  • Mammalian cells
  • Orip/EBNA-1
  • Transduction


Dive into the research topics of 'An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression'. Together they form a unique fingerprint.

Cite this